Answer
It is licensed for defined adults with highly active relapsing-remitting MS, including disease that remains highly active despite another disease-modifying treatment or is rapidly evolving and severe.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.